Chronic obstructive pulmonary disease in farmers and agricultural workers – an overview
More details
Hide details
Chair of Internal Medicine and Department of Internal Medicine in Nursing, Medical University of Lublin, Poland; Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Poland
Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Poland
Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Poland; Institute of Rural Health in Lublin, Poland
Chair of Internal Medicine and Department of Internal Medicine in Nursing, Medical University of Lublin, Poland
Ann Agric Environ Med. 2011;18(2):310–313
Chronic obstructive pulmonary disease (COPD) is a common inflammatory disease of the airways characterized by airflow obstruction that is not fully reversible. It is most often caused by smoking, but other factors including exposure to biological agents can play a significant role in its development. It is one of the leading causes of morbidity and mortality among the adult population worldwide. In Poland, symptoms of chronic impairment of airflow are present in 8.5% of males and 4.9% of females. Livestock farmers have an increased risk of chronic bronchitis, COPD, and reduced forced expiratory volume (FEV1). COPD in farmers working inside confinement buildings is related to organic dust exposure and may become severe. The management of COPD is aimed at improving the patient’s quality of life and functional status. Currently, apart from lung transplantation, there is no treatment that would significantly improve lung function and decrease mortality. This led us to the conclusion that we should study the problem further, and cautiously monitor patients to help efforts aimed at the prevention of respiratory diseases among farmers and agricultural workers.
Barr RG, Bluemke DA, Ahmed FS, et al. Percent emphysema, airfl ow obstruction, and impaired left ventricular fi lling. N Engl J Med 2010;362:217-227.
Feary JR, Rodrigues LC, Smith CJ, et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Th orax 2010, 65:956-962.
Ferguson GT, Calverley PM, Anderson JA, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the Towards a Revolution in COPD Health study. Chest 2009;136:1456- 1465.
Hung WW, Wisnivesky JP, Siu AL, Ross JS. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;180:134-137.
Incalzi RA, Corsonello A, Pedone C, et al. Chronic renal failure: a neglected comorbidity of COPD. Chest 2010;137:831-838.
Light RW, Merrill EJ, Despars JA, et al. Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. Chest 1985;87:35-38.
Schneider C, Jick SS, Bothner U, Meier CR. COPD and the risk of depression. Chest 2010;137:341-347.
Sin DD, Man SF: Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Th orac Soc 2005;2:8.
Watz H, Waschki B, Meyer T. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinfl ation. Chest 2010;138:32-38.
Kozielski J, Chazan R, Górecka D, Jahnz-Różyk K, Jędrychowski W, Kuna P, et al. Zalecenia Polskiego Towarzystwa Fizjopneumonologicznego rozpoznawanie i leczenie przewlekłej obturacyjnej choroby płuc. (Diagnosis and therapy of chronic obstructive pulmonary disease- -recommendations of the Polish Phtisiopneumonology Society). Pneumonol Alergol Pol 2002;70 sup. 2:2-42 (in Polish).
Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349(9063):1436-1442.
Atsou K, Chouaid C, Hejblum G. Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med 2011;9:7.
Antó JM, Vermeire P, Sunyer J. Chronic obstructive pulmonary disease. Eur Respir Monogr 2000;5(15):1-22.
Pływaczewski R, Bednarek M, Jonczak L, Zieliński J. Prevalence of COPD in Warsaw population. Pneumonol Alergol Pol 2003;71(7-8):329-335.
Ezzati M. Indoor air pollution and health in developing countries. Lancet 2005;366(9480):104-106.
Regalado J, Perez-Padilla R, Sansores R, Paramo-Ramirez JI, Brauer M, Pare P, Vedal S. Th e Eff ect of Biomass Burning on Respiratory Symptoms and Lung Function in Rural Mexican Women. Am J Respir Crit Care Med 2006;174(8):901-905.
Eduard W, Pearce N, Douwes J. Chronic bronchitis, COPD, and lung function in farmers: the role of biological agents. Chest 2009;136(3):716- 725.
Dalphin JC, Bildstein F, Pernet D, Dubiez A, Depierre A. Prevalence of chronic bronchitis and respiratory function in a group of dairy farmers in the French Doubs province. Chest 1989;95(6):1244-1247.
Greskevitch M, Kullman G, Bang KM, Mazurek JM. Respiratory disease in agricultural workers: mortality and morbidity statistics. J Agromedicine 2007;12(3):5-10.
Monsó E, Riu E, Radon K, Magarolas R, Danuser B, Iversen M, Morera J, Nowak D. Chronic obstructive pulmonary disease in never-smoking animal farmers working inside confi nement buildings. Am J Ind Med 2004;46(4):357-62.
Badgett RG, Tanaka DJ, Hunt DK, et al. Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical fi ndings alone? Am J Med 1993;94:188-196.
Sethi S, Murphy TF: Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359(22):2355-65.
Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, et al. A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identifi cation of Two Major Susceptibility Loci. PLoS Genet 2009;5(3): e1000421.
Wilk JB, Chen T-h, Gottlieb DJ, Walter RE, Nagle MW, et al. A GenomeWide Association Study of Pulmonary Function Measures in the Framingham Heart Study. PLoS Genet 2009;5(3):e1000429.
Van Durme YM, Eijgelsheim M, Joos GF, Hofman A, Uitterlinden AG, Brusselle GG, Stricker BH. Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study. Eur Respir J 2010;36(1):89-95.
Obeidat M, Wain LV, Shrine N, Kalsheker N, Artigas MS, et al. A Comprehensive Evaluation of Potential Lung Function Associated Genes in the SpiroMeta General Population Sample. PLoS ONE 2011;6(5):e19382.
Sahlander K, Larsson K, Palmberg L. Altered innate immune response in farmers and smokers. Innate Immun 2010;16(1):27-38.
Sundblad BM, von Scheele I, Palmberg L, Olsson M, Larsson K. Repeated exposure to organic material alters infl ammatory and physiological airway responses. Eur Respir J 2009;34(1):80-88.
Milanowski J. Th e infl uence of organic dust on the chemotaxis of lung cells. Experimental studies. Pneumonol Alergol Pol 1996;64 Suppl 1:78-89.
Milanowski J, Sorenson WG, Lewis DM, Dutkiewicz J. Chemotaxis of alveolar macrophages and neutrophils in response to microbial products derived from organic dust. J Investig Allergol Clin Immunol 1995;5(4):221-7.
Golec M, Reichel C, Mackiewicz B, Skorska C, Curzytek K, Lemieszek M, et al. Cathelicidin LL-37, granzymes, TGF-beta1 and cytokines levels in induced sputum from farmers with and without COPD. Ann Agric Environ Med 2009;16(2):289-97.
Hospers JJ, Postma DS, Rijcken B, et al. Histamine airway hyperresponsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 2000;356:1313.
Breen D, Churches T, Hawker F, Torzillo PJ. Acute respiratory failure secondary to chronic obstructive pulmonary disease treated in the intensive care unit: a long term follow up study. Th orax 2002;57:29-33.
Seneff MG, Wagner DP, Wagner RP. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995;274:1852.
Martin TR, Lewis SW, Albert RK. Th e prognosis of patients with chronic obstructive pulmonary disease aft er hospitalization for acute respiratory failure. Chest 1982;82:310-314.
Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-555.
Rice KL, Dewan N, Bloomfi eld HE, Grill J, Schult TM, Nelson DB, et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2010;182(7):890-6.